Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation

Abstract Cleavage and polyadenylation (CPA) is responsible for 3′ end processing of eukaryotic poly(A)+ RNAs and preludes transcriptional termination. JTE-607, which targets CPSF-73, is the first known CPA inhibitor (CPAi) in mammalian cells. Here we show that JTE-607 perturbs gene expression throug...

Full description

Bibliographic Details
Main Authors: Yange Cui, Luyang Wang, Qingbao Ding, Jihae Shin, Joel Cassel, Qin Liu, Joseph M. Salvino, Bin Tian
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-39793-8
_version_ 1797752730576486400
author Yange Cui
Luyang Wang
Qingbao Ding
Jihae Shin
Joel Cassel
Qin Liu
Joseph M. Salvino
Bin Tian
author_facet Yange Cui
Luyang Wang
Qingbao Ding
Jihae Shin
Joel Cassel
Qin Liu
Joseph M. Salvino
Bin Tian
author_sort Yange Cui
collection DOAJ
description Abstract Cleavage and polyadenylation (CPA) is responsible for 3′ end processing of eukaryotic poly(A)+ RNAs and preludes transcriptional termination. JTE-607, which targets CPSF-73, is the first known CPA inhibitor (CPAi) in mammalian cells. Here we show that JTE-607 perturbs gene expression through both transcriptional readthrough and alternative polyadenylation (APA). Sensitive genes are associated with features similar to those previously identified for PCF11 knockdown, underscoring a unified transcriptomic signature of CPAi. The degree of inhibition of an APA site by JTE-607 correlates with its usage level and, consistently, cells with elevated CPA activities, such as those with induced overexpression of FIP1, display greater transcriptomic disturbances when treated with JTE-607. Moreover, JTE-607 causes S phase crisis and is hence synergistic with inhibitors of DNA damage repair pathways. Together, our data reveal CPA activity and proliferation rate as determinants of CPAi-mediated cell death, raising the possibility of using CPAi as an adjunct therapy to suppress certain cancers.
first_indexed 2024-03-12T17:07:40Z
format Article
id doaj.art-e9b3e1159ab1464199de78e8383a1b46
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-12T17:07:40Z
publishDate 2023-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-e9b3e1159ab1464199de78e8383a1b462023-08-06T11:19:20ZengNature PortfolioNature Communications2041-17232023-08-0114112010.1038/s41467-023-39793-8Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylationYange Cui0Luyang Wang1Qingbao Ding2Jihae Shin3Joel Cassel4Qin Liu5Joseph M. Salvino6Bin Tian7Gene Expression and Regulation Program, and Center for Systems and Computational Biology, The Wistar InstituteGene Expression and Regulation Program, and Center for Systems and Computational Biology, The Wistar InstituteGene Expression and Regulation Program, and Center for Systems and Computational Biology, The Wistar InstituteDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical SchoolMolecular and Cellular Oncogenesis Program, The Wistar InstituteMolecular and Cellular Oncogenesis Program, The Wistar InstituteMolecular and Cellular Oncogenesis Program, The Wistar InstituteGene Expression and Regulation Program, and Center for Systems and Computational Biology, The Wistar InstituteAbstract Cleavage and polyadenylation (CPA) is responsible for 3′ end processing of eukaryotic poly(A)+ RNAs and preludes transcriptional termination. JTE-607, which targets CPSF-73, is the first known CPA inhibitor (CPAi) in mammalian cells. Here we show that JTE-607 perturbs gene expression through both transcriptional readthrough and alternative polyadenylation (APA). Sensitive genes are associated with features similar to those previously identified for PCF11 knockdown, underscoring a unified transcriptomic signature of CPAi. The degree of inhibition of an APA site by JTE-607 correlates with its usage level and, consistently, cells with elevated CPA activities, such as those with induced overexpression of FIP1, display greater transcriptomic disturbances when treated with JTE-607. Moreover, JTE-607 causes S phase crisis and is hence synergistic with inhibitors of DNA damage repair pathways. Together, our data reveal CPA activity and proliferation rate as determinants of CPAi-mediated cell death, raising the possibility of using CPAi as an adjunct therapy to suppress certain cancers.https://doi.org/10.1038/s41467-023-39793-8
spellingShingle Yange Cui
Luyang Wang
Qingbao Ding
Jihae Shin
Joel Cassel
Qin Liu
Joseph M. Salvino
Bin Tian
Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
Nature Communications
title Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
title_full Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
title_fullStr Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
title_full_unstemmed Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
title_short Elevated pre-mRNA 3′ end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
title_sort elevated pre mrna 3 end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation
url https://doi.org/10.1038/s41467-023-39793-8
work_keys_str_mv AT yangecui elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT luyangwang elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT qingbaoding elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT jihaeshin elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT joelcassel elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT qinliu elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT josephmsalvino elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation
AT bintian elevatedpremrna3endprocessingactivityincancercellsrendersvulnerabilitytoinhibitionofcleavageandpolyadenylation